Meeting investors', buyers', and sellers' goals isn't easy. Bonum's Chief Business Officer Neela Patel offers advice on how to negotiate a winning deal that leaves all parties positioned for success. Check out her insights in the Spring 2024 Issue of Drug Discovery World, starting on page 62: https://lnkd.in/gjdARyER
Bonum Therapeutics’ Post
More Relevant Posts
-
Author/Co-founder of NewGen Mindset Podcast /Book - "Millennial Economics: Structuring Economic Consciousness In Individuals"
🌿 🏛️In the tenth episode of NewGen Mindset's "Capital Market Series," Nic and Dan sit down with Eric Ronsse from The Good Shroom Co. We begin by getting to know Eric and his past experiences, which led him to venture into the cannabis industry and establish the public company known as The Good Shroom Co. Eric provides an overview of the cannabis landscape and the opportunities his company has been able to seize. The Good Shroom Co. operates on three fundamental pillars that define their operations and success: Analytics, Network/Logistics, and Branding. Having established themselves as a reputable and reliable partner in their home market of Quebec, these pillars guide their business strategy. As a non-producer marijuana company, they focus on market feedback and their well-established network of producers to create new brands in various segments. Their products include offerings in the hash, flower, and edibles segments, with ongoing R&D projects to support their national strategy. 🔥📈With the cannabis industry still in its infancy as a legal market, there are companies worth watching that are well-positioned to evolve and grow alongside it. The Good Shroom Co. is one such company. Capital Market Series - 010 with The Good Shroom Co TSXV: MUSH.V Website: https://lnkd.in/eziqmSMe 🎙️ Full Episode Here: https://lnkd.in/eWy6kjT7 NewGen Mindset Daniel Kozel Scott Jardin #cannabis #sector #investing #finance #cashflow #profits #markets #canada #usa #growth #edibles #branding #network #analytics #opportunities #mush #marijuana #thegoodshroomCo *Disclaimer: None of the information provided in this episode should be considered investment advice and should only be viewed for informational purposes.*
The Good Shroom Co (MUSH.V) - Capital Market Series w/ Eric Ronsse - CEO
https://www.youtube.com/
To view or add a comment, sign in
-
We previously published the three elements that need to converge to create a successful angel network. The elements are Investor Members, Deal Flow and a Robust Process. In 2024 the Chemical Angel Network identified several specific objects to support Investor Members. - Grow membership to 70 (Investors/partners/associates) - Extend visitor invitations allowing accredited investor to view presenting companies. If you are an accredited investor and interested in joining a meeting as a guest, please reach out to one of the Chemical Angel Directors. Bruce Weiller, Ph.D., Damoder Reddy, Frank L. Slejko, Linda O'Keefe, CPA, CGMA or Mark Vreeke
To view or add a comment, sign in
-
check out this awesome Lexology contribution I co-authored ☺️!
We are pleased to have authored the UK, Germany and Canada insight on joint ventures for Lexology Getting The Deal Through 2024 guide. Our contributions were led by Gareth Baker and Bernardine Adkins (UK), Andreas Woelfle, Florian Holfeld, LL.M. (Germany), and Chris Eustace, Ian Macdonald, Paul Carenza, Brianne Quesnel and Michelle K (Canada). Find out more and read the full guide 👉 https://gowlg.co/3SHnYSQ Lexology #JointVentures
To view or add a comment, sign in
-
-
Joshua Galloway, our Senior Client Success Manager delves into why 'Transparency' stands out as his most cherished company value. He believes in clear communication and honest interactions as the bedrock of trust and integrity in the cannabis industry.If you agree, please share your thoughts in the comment section below. Let us know your opinion! #LucidGreen #CompanyValues #Transparency #CannabisIndustry #TeamInsights #LucidID
Josh Explores Transparency: Lucid Green's Core Value Insight
https://www.youtube.com/
To view or add a comment, sign in
-
🚀 Update from Qthena! 🚀 We've just released our latest insights: "2023's Unitary Patent Filings Insights by EP Agent." Dive deep into the trends shaping the future of patent filings and discover the top EP agents leading the way in Unitary Patent requests. Powered by ipQuants' comprehensive EPO analytics, Qthena is here to transform your strategic patent planning with actionable data. Don't miss out on these crucial insights! 🔍 Explore the full insights : https://lnkd.in/e4PUcSyt
To view or add a comment, sign in
-
ICYMI: my analysis of corporate VC trends in biopharma over the past few years, for Citeline Commercial:
To view or add a comment, sign in
More from this author
-
The Business of Biotech Highlights Bonum CEO John Mulligan & CBO Neela Patel
Bonum Therapeutics 7mo -
A BD Checklist: Best Practices for Partnering with Pharma - by Neela Patel
Bonum Therapeutics 9mo -
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics - by Justin Killebrew
Bonum Therapeutics 1y